Literature DB >> 28952650

The mitochondrion: a central architect of copper homeostasis.

Zakery N Baker1, Paul A Cobine, Scot C Leary.   

Abstract

All known eukaryotes require copper for their development and survival. The essentiality of copper reflects its widespread use as a co-factor in conserved enzymes that catalyze biochemical reactions critical to energy production, free radical detoxification, collagen deposition, neurotransmitter biosynthesis and iron homeostasis. However, the prioritized use of copper poses an organism with a considerable challenge because, in its unbound form, copper can potentiate free radical production and displace iron-sulphur clusters to disrupt protein function. Protective mechanisms therefore evolved to mitigate this challenge and tightly regulate the acquisition, trafficking and storage of copper such that the metal ion is rarely found in its free form in the cell. Findings by a number of groups over the last ten years emphasize that this regulatory framework forms the foundation of a system that is capable of monitoring copper status and reprioritizing copper usage at both the cellular and systemic levels of organization. While the identification of relevant molecular mechanisms and signaling pathways has proven to be difficult and remains a barrier to our full understanding of the regulation of copper homeostasis, mounting evidence points to the mitochondrion as a pivotal hub in this regard in both healthy and diseased states. Here, we review our current understanding of copper handling pathways contained within the organelle and consider plausible mechanisms that may serve to functionally couple their activity to that of other cellular copper handling machinery to maintain copper homeostasis.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28952650      PMCID: PMC5688007          DOI: 10.1039/c7mt00221a

Source DB:  PubMed          Journal:  Metallomics        ISSN: 1756-5901            Impact factor:   4.526


  123 in total

1.  Functional partnership of the copper export machinery and glutathione balance in human cells.

Authors:  Yuta Hatori; Sara Clasen; Nesrin M Hasan; Amanda N Barry; Svetlana Lutsenko
Journal:  J Biol Chem       Date:  2012-05-30       Impact factor: 5.157

2.  Mutations in SCO2 are associated with a distinct form of hypertrophic cardiomyopathy and cytochrome c oxidase deficiency.

Authors:  M Jaksch; I Ogilvie; J Yao; G Kortenhaus; H G Bresser; K D Gerbitz; E A Shoubridge
Journal:  Hum Mol Genet       Date:  2000-03-22       Impact factor: 6.150

3.  AMP-activated protein kinase induces a p53-dependent metabolic checkpoint.

Authors:  Russell G Jones; David R Plas; Sara Kubek; Monica Buzzai; James Mu; Yang Xu; Morris J Birnbaum; Craig B Thompson
Journal:  Mol Cell       Date:  2005-04-29       Impact factor: 17.970

4.  Mutations in COA6 cause cytochrome c oxidase deficiency and neonatal hypertrophic cardiomyopathy.

Authors:  Fabian Baertling; Mariel A M van den Brand; Jozef L Hertecant; Aisha Al-Shamsi; Lambert P van den Heuvel; Felix Distelmaier; Ertan Mayatepek; Jan A Smeitink; Leo G J Nijtmans; Richard J T Rodenburg
Journal:  Hum Mutat       Date:  2014-11-18       Impact factor: 4.878

5.  Glutathione deficiency in patients with mitochondrial disease: implications for pathogenesis and treatment.

Authors:  I P Hargreaves; Y Sheena; J M Land; S J R Heales
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

6.  Mitochondrial structure and function in the untreated Jackson toxic milk (tx-j) mouse, a model for Wilson disease.

Authors:  Eve A Roberts; Brian H Robinson; Suyun Yang
Journal:  Mol Genet Metab       Date:  2007-11-05       Impact factor: 4.797

7.  Mitochondrial disease genes COA6, COX6B and SCO2 have overlapping roles in COX2 biogenesis.

Authors:  Alok Ghosh; Anthony T Pratt; Shivatheja Soma; Sarah G Theriault; Aaron T Griffin; Prachi P Trivedi; Vishal M Gohil
Journal:  Hum Mol Genet       Date:  2015-12-15       Impact factor: 6.150

8.  Three-dimensional structure of the human copper transporter hCTR1.

Authors:  Christopher J De Feo; Stephen G Aller; Gnana S Siluvai; Ninian J Blackburn; Vinzenz M Unger
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-24       Impact factor: 11.205

9.  Kinetic control by limiting glutaredoxin amounts enables thiol oxidation in the reducing mitochondrial intermembrane space.

Authors:  Kerstin Kojer; Valentina Peleh; Gaetano Calabrese; Johannes M Herrmann; Jan Riemer
Journal:  Mol Biol Cell       Date:  2014-11-12       Impact factor: 4.138

10.  SIRT3 regulates cellular iron metabolism and cancer growth by repressing iron regulatory protein 1.

Authors:  S M Jeong; J Lee; L W S Finley; P J Schmidt; M D Fleming; M C Haigis
Journal:  Oncogene       Date:  2014-06-09       Impact factor: 9.867

View more
  30 in total

Review 1.  Wilson disease.

Authors:  Anna Członkowska; Tomasz Litwin; Petr Dusek; Peter Ferenci; Svetlana Lutsenko; Valentina Medici; Janusz K Rybakowski; Karl Heinz Weiss; Michael L Schilsky
Journal:  Nat Rev Dis Primers       Date:  2018-09-06       Impact factor: 52.329

2.  Golgi-Dependent Copper Homeostasis Sustains Synaptic Development and Mitochondrial Content.

Authors:  Cortnie Hartwig; Gretchen Macías Méndez; Shatabdi Bhattacharjee; Alysia D Vrailas-Mortimer; Stephanie A Zlatic; Amanda A H Freeman; Avanti Gokhale; Mafalda Concilli; Erica Werner; Christie Sapp Savas; Samantha Rudin-Rush; Laura Palmer; Nicole Shearing; Lindsey Margewich; Jacob McArthy; Savanah Taylor; Blaine Roberts; Vladimir Lupashin; Roman S Polishchuk; Daniel N Cox; Ramon A Jorquera; Victor Faundez
Journal:  J Neurosci       Date:  2020-11-18       Impact factor: 6.167

3.  The mammalian phosphate carrier SLC25A3 is a mitochondrial copper transporter required for cytochrome c oxidase biogenesis.

Authors:  Aren Boulet; Katherine E Vest; Margaret K Maynard; Micah G Gammon; Antoinette C Russell; Alexander T Mathews; Shelbie E Cole; Xinyu Zhu; Casey B Phillips; Jennifer Q Kwong; Sheel C Dodani; Scot C Leary; Paul A Cobine
Journal:  J Biol Chem       Date:  2017-12-13       Impact factor: 5.157

4.  Multimodal LA-ICP-MS and nanoSIMS imaging enables copper mapping within photoreceptor megamitochondria in a zebrafish model of Menkes disease.

Authors:  Cheri M Ackerman; Peter K Weber; Tong Xiao; Bao Thai; Tiffani J Kuo; Emily Zhang; Jennifer Pett-Ridge; Christopher J Chang
Journal:  Metallomics       Date:  2018-03-06       Impact factor: 4.526

Review 5.  Dynamic and cell-specific transport networks for intracellular copper ions.

Authors:  Svetlana Lutsenko
Journal:  J Cell Sci       Date:  2021-11-04       Impact factor: 5.285

6.  High-dose copper activates p53-independent apoptosis through the induction of nucleolar stress in human cell lines.

Authors:  Chieh-Hsin Chen; Yi-Ting Chou; Ya-Wen Yang; Kai-Yin Lo
Journal:  Apoptosis       Date:  2021-10-27       Impact factor: 4.677

Review 7.  Sirtuins as molecular targets, mediators, and protective agents in metal-induced toxicity.

Authors:  Alexey A Tinkov; Michael Aschner; Thuy T Nguyen; Abel Santamaria; Aaron B Bowman; Aleksandra Buha Djordjevic; Monica Maria Bastos Paoliello; Anatoly V Skalny
Journal:  Arch Toxicol       Date:  2021-05-24       Impact factor: 5.153

8.  Repurposing elesclomol, an investigational drug for the treatment of copper metabolism disorders.

Authors:  Vishal M Gohil
Journal:  Expert Opin Investig Drugs       Date:  2020-11-05       Impact factor: 6.206

Review 9.  Getting out what you put in: Copper in mitochondria and its impacts on human disease.

Authors:  Paul A Cobine; Stanley A Moore; Scot C Leary
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2020-10-02       Impact factor: 4.739

Review 10.  Mechanisms of Metal-Induced Mitochondrial Dysfunction in Neurological Disorders.

Authors:  Hong Cheng; Bobo Yang; Tao Ke; Shaojun Li; Xiaobo Yang; Michael Aschner; Pan Chen
Journal:  Toxics       Date:  2021-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.